The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immune-Mediated Inflammatory Diseases Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.
The global Immune-Mediated Inflammatory Diseases Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immune-Mediated Inflammatory Diseases Treatment in various end use industries. The expanding demands from the Hospitals, Pharmacy Store and Online Pharmacy Stroe,, are propelling Immune-Mediated Inflammatory Diseases Treatment market. Targeted biologic therapies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Novel therapies segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune-Mediated Inflammatory Diseases Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immune-Mediated Inflammatory Diseases Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune-Mediated Inflammatory Diseases Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune-Mediated Inflammatory Diseases Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune-Mediated Inflammatory Diseases Treatment covered in this report include GlaxoSmithKline, Eli Lilly, AstraZeneca, Bristol-Myers, Sanofi, Roche, Enlivex Therapeutics, Immune Pharmaceuticals and Tanabe Pharma, etc.
The global Immune-Mediated Inflammatory Diseases Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Global Immune-Mediated Inflammatory Diseases Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune-Mediated Inflammatory Diseases Treatment market, Segment by Type:
Targeted biologic therapies
Novel therapies
Global Immune-Mediated Inflammatory Diseases Treatment market, by Application
Hospitals
Pharmacy Store
Online Pharmacy Stroe
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immune-Mediated Inflammatory Diseases Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.
The global Immune-Mediated Inflammatory Diseases Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immune-Mediated Inflammatory Diseases Treatment in various end use industries. The expanding demands from the Hospitals, Pharmacy Store and Online Pharmacy Stroe,, are propelling Immune-Mediated Inflammatory Diseases Treatment market. Targeted biologic therapies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Novel therapies segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune-Mediated Inflammatory Diseases Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immune-Mediated Inflammatory Diseases Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune-Mediated Inflammatory Diseases Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune-Mediated Inflammatory Diseases Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune-Mediated Inflammatory Diseases Treatment covered in this report include GlaxoSmithKline, Eli Lilly, AstraZeneca, Bristol-Myers, Sanofi, Roche, Enlivex Therapeutics, Immune Pharmaceuticals and Tanabe Pharma, etc.
The global Immune-Mediated Inflammatory Diseases Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Global Immune-Mediated Inflammatory Diseases Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune-Mediated Inflammatory Diseases Treatment market, Segment by Type:
Targeted biologic therapies
Novel therapies
Global Immune-Mediated Inflammatory Diseases Treatment market, by Application
Hospitals
Pharmacy Store
Online Pharmacy Stroe
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immune-Mediated Inflammatory Diseases Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Immune-Mediated Inflammatory Diseases Treatment
1.1 Immune-Mediated Inflammatory Diseases Treatment Market Overview
1.1.1 Immune-Mediated Inflammatory Diseases Treatment Product Scope
1.1.2 Immune-Mediated Inflammatory Diseases Treatment Market Status and Outlook
1.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2018-2029)
1.4 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Region (2018-2023)
1.5 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2029)
1.6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2029)
1.6.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2029)
1.6.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2029)
2 Immune-Mediated Inflammatory Diseases Treatment Market by Type
2.1 Introduction
2.1.1 Targeted biologic therapies
2.1.2 Novel therapies
2.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Type (2018-2029)
3 Immune-Mediated Inflammatory Diseases Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Pharmacy Store
3.1.3 Online Pharmacy Stroe
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immune-Mediated Inflammatory Diseases Treatment Revenue Breakdown by Application (2018-2029)
4 Immune-Mediated Inflammatory Diseases Treatment Competition Analysis by Players
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2022)
4.3 Date of Key Players Enter into Immune-Mediated Inflammatory Diseases Treatment Market
4.4 Global Top Players Immune-Mediated Inflammatory Diseases Treatment Headquarters and Area Served
4.5 Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Immune-Mediated Inflammatory Diseases Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.1.4 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 GlaxoSmithKline Recent Developments
5.2 Eli Lilly
5.2.1 Eli Lilly Profile
5.2.2 Eli Lilly Main Business
5.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.2.4 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Eli Lilly Recent Developments
5.3 AstraZeneca
5.3.1 AstraZeneca Profile
5.3.2 AstraZeneca Main Business
5.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.3.4 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Bristol-Myers Recent Developments
5.4 Bristol-Myers
5.4.1 Bristol-Myers Profile
5.4.2 Bristol-Myers Main Business
5.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.4.4 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Bristol-Myers Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.5.4 Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.6.4 Roche Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Enlivex Therapeutics
5.7.1 Enlivex Therapeutics Profile
5.7.2 Enlivex Therapeutics Main Business
5.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.7.4 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Enlivex Therapeutics Recent Developments
5.8 Immune Pharmaceuticals
5.8.1 Immune Pharmaceuticals Profile
5.8.2 Immune Pharmaceuticals Main Business
5.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.8.4 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Immune Pharmaceuticals Recent Developments
5.9 Tanabe Pharma
5.9.1 Tanabe Pharma Profile
5.9.2 Tanabe Pharma Main Business
5.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Products, Services and Solutions
5.9.4 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Tanabe Pharma Recent Developments
6 North America
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immune-Mediated Inflammatory Diseases Treatment Market Dynamics
11.1 Immune-Mediated Inflammatory Diseases Treatment Industry Trends
11.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers
11.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges
11.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
